Cantel Medical, Olympus Corporation, STERIS Plcare Dominating the U.S Endoscope Reprocessing Market in 2019

U.S Endoscope Reprocessing Market is projected to register a CAGR of 7.2% in the forecast period of 2020 to 2027. The years considered for study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/us-endoscope-reprocessing-market

U.S endoscope reprocessing market is a highly consolidated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario.

The market has a prominent growth in upcoming years due to growing demand for the endoscope reprocessing products, support from government organisations and innovative product launches of U.S endoscope reprocessing. The market has witnessed developments in terms of product launches to enhance the product portfolio to meet the rising demand of innovative endoscope reprocessing products. For instance, In November, Steelco S.p.A launched two products that are 18 DIN trays capacity washer disinfectors PWD 8626 and PWD 8628. They use Power Pulse Cleaning to diminish manual cleaning; it also saves water and energy. Therefore, it will lead to product base expansion and increased revenue generation.

The major players dealing in the U.S. endoscope reprocessing market are introducing strong range of product portfolio. This has also helped the company to maximize the sales with enhanced product portfolio.

Cantel Medical is the dominating player in the U.S endoscope reprocessing market and accounts the highest market share in 2019, which is followed by Olympus Corporation, STERIS plc, ASP, CONMED Corporation, Cook Medical, Custom Ultrasonics, Inc. Diversatek, Inc., Getinge AB, Metrex Research, LLC, Richard Wolf GmbH, and Steelco S.p.A.  among others.

U.S. Endoscope Reprocessing MarketCantel Medical

Cantel Medical is headquartered in New Jersey, U.S.The company focuses on providing infection prevention products and services to save lives of people. Cantel Medical has approximately 2,775 employees in the company. The company has various business segments like medical, life sciences, dental and dialysis, in which medical is the market focused segment. The company also has various company categories like medivators, mar cor purification, crosstexin which medivators is the market focused company category. The company has various product & service categories like endoscope reprocessing, endoscopy procedure products, U.K. Products, renal systems, therapeutic technologies, bioredox decontamination service, custom development,procedure products;endoscope reprocessing is the market focused category.

The company is continuously engaged in strategic relationship to enhance the product of the endoscope reprocessingsuch as,

  • In March 2018, Cantel Medical stated that it has acquired Aexis Medical BVBA, a company which specializes in software applications which is made to manage and control workflows for hospitals and healthcare professionals on reprocessing instruments. This will help as it extends global leadership in the prevention of infections by joining the knowledge processing market for healthcare.

The company has its presence in Asia-Pacific, Europe, North America and South America.The company has various subsidiaries such as MEDIVATORS Inc. (U.S.), BHT Hygienetechnik GmbH (Germany), Cantel Medical (Malaysia) Sdn. Bhd. (Malaysia), and Minntech Japan K.K. (Japan) among others among others.

Olympus Corporation of the Americas

Olympus Corporation of the Americas headquartered in New York, U.S. wasestablished in 1968. The company aims to strengthen their position in endoscopy by continuously innovating technologies in reusable devices and pioneering the nascent disposable endoscopy segment, and shifting toward a service-based and procedure-based commercial model.The company has multiple business segments such as medical technologies, life sciences, industrial solutions and cameras and audio products. In which medical technologies is the market focused segment. The company has wide range of product category such as cameras and audio, medical and surgical, life science solutions, industrial solutions, in it medical and surgical is the market focused category.

  • In April, 2018 FDA approved the authentication of System plus 83 AERs of Custom Ultrasonics, Check casing it should be in sentence case Inc. Hence, System 83 plus AERs may now be used to reprocess only the Olympus TJF-Q180V duodenoscope and the Pentax ED-3490TK duodenoscope. It will lead to greater revenues and an establishment of name in the market. 

The company has its presence in North America and South America. The company has subsidiaries such as Spiration (U.S.), Olympus Memory Works America Inc (U.S.), Olympus Diagnostic Systems Group (U.S.), Bacus Laboratories, Inc (U.S.) among others among others.

STERIS plc

STERIS plc headquartered in Dublin, Irelandwas founded in 1985. The company has 12,000 employees in the company. The company is focused on medical device customers, pharmaceutical and healthcare; it is also a provider of procedural products and services.The company has multiple businesscategories such as healthcare products, healthcare specialty services, life sciences, applied sterilization technologies. In it, healthcare products are the market focus segment. The company has various product categories such as hospitals & surgery centers, medical device, pharmaceutical& biotechnology manufacturers, research & laboratory, and contract sterilization services. In it, hospitals & surgery centers are the market focus segment.

The company has presence in Asia-Pacific, Europe, Middle East & Africa, North America and South America. The company has various subsidiaries such as American Sterilizer Company (America), US Endoscopy, Inc. (U.S.), Biotest Laboratories, Inc. (U.S.), Healthtex Synergy Ltd (U.K), STERIS (BVI) I Ltd (UAE) among others